Request Free Sample ×
US Mobile Health Market Research Report - Forecast 2035 Infographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Mobile Health Market

ID: MRFR/HCIT/16445-HCR
100 Pages
Nidhi Mandole
Last Updated: April 06, 2026

US Mobile Health Market Research Report: Size, Share, Trend Analysis By Applications (Health Tracking, Remote Patient Monitoring, Medication Management, Fitness Management), By Device Type (Wearable Devices, Smartphones, Tablets, Personal Digital Assistants), By Service Type (Consultation Services, Monitoring Services, Data Analytics Services) and By End Users (Patients, Healthcare Providers, Insurance Companies, Pharmaceutical Companies) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US Mobile Health Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Life Sciences, BY Application (USD Billion)
  49.     4.1.1 Chronic Disease Management
  50.     4.1.2 Health and Fitness Tracking
  51.     4.1.3 Telehealth Services
  52.     4.1.4 Medication Management
  53.   4.2 Life Sciences, BY Technology (USD Billion)
  54.     4.2.1 Wearable Devices
  55.     4.2.2 Applications
  56.     4.2.3 Remote Patient Monitoring
  57.     4.2.4 Telemedicine Platforms
  58.   4.3 Life Sciences, BY End-use (USD Billion)
  59.     4.3.1 Healthcare Providers
  60.     4.3.2 Patients
  61.     4.3.3 Insurance Companies
  62.     4.3.4 Pharmaceutical Companies
  63.   4.4 Life Sciences, BY Component (USD Billion)
  64.     4.4.1 Hardware
  65.     4.4.2 Software
  66.     4.4.3 Services
  67. 5 SECTION V: COMPETITIVE ANALYSIS
  68.   5.1 Competitive Landscape
  69.     5.1.1 Overview
  70.     5.1.2 Competitive Analysis
  71.     5.1.3 Market share Analysis
  72.     5.1.4 Major Growth Strategy in the Life Sciences
  73.     5.1.5 Competitive Benchmarking
  74.     5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences
  75.     5.1.7 Key developments and growth strategies
  76.       5.1.7.1 New Product Launch/Service Deployment
  77.       5.1.7.2 Merger & Acquisitions
  78.       5.1.7.3 Joint Ventures
  79.     5.1.8 Major Players Financial Matrix
  80.       5.1.8.1 Sales and Operating Income
  81.       5.1.8.2 Major Players R&D Expenditure. 2023
  82.   5.2 Company Profiles
  83.     5.2.1 Apple Inc (US)
  84.       5.2.1.1 Financial Overview
  85.       5.2.1.2 Products Offered
  86.       5.2.1.3 Key Developments
  87.       5.2.1.4 SWOT Analysis
  88.       5.2.1.5 Key Strategies
  89.     5.2.2 Samsung Electronics (KR)
  90.       5.2.2.1 Financial Overview
  91.       5.2.2.2 Products Offered
  92.       5.2.2.3 Key Developments
  93.       5.2.2.4 SWOT Analysis
  94.       5.2.2.5 Key Strategies
  95.     5.2.3 Philips Healthcare (NL)
  96.       5.2.3.1 Financial Overview
  97.       5.2.3.2 Products Offered
  98.       5.2.3.3 Key Developments
  99.       5.2.3.4 SWOT Analysis
  100.       5.2.3.5 Key Strategies
  101.     5.2.4 Cerner Corporation (US)
  102.       5.2.4.1 Financial Overview
  103.       5.2.4.2 Products Offered
  104.       5.2.4.3 Key Developments
  105.       5.2.4.4 SWOT Analysis
  106.       5.2.4.5 Key Strategies
  107.     5.2.5 McKesson Corporation (US)
  108.       5.2.5.1 Financial Overview
  109.       5.2.5.2 Products Offered
  110.       5.2.5.3 Key Developments
  111.       5.2.5.4 SWOT Analysis
  112.       5.2.5.5 Key Strategies
  113.     5.2.6 Allscripts Healthcare Solutions (US)
  114.       5.2.6.1 Financial Overview
  115.       5.2.6.2 Products Offered
  116.       5.2.6.3 Key Developments
  117.       5.2.6.4 SWOT Analysis
  118.       5.2.6.5 Key Strategies
  119.     5.2.7 Fitbit Inc (US)
  120.       5.2.7.1 Financial Overview
  121.       5.2.7.2 Products Offered
  122.       5.2.7.3 Key Developments
  123.       5.2.7.4 SWOT Analysis
  124.       5.2.7.5 Key Strategies
  125.     5.2.8 Medtronic (US)
  126.       5.2.8.1 Financial Overview
  127.       5.2.8.2 Products Offered
  128.       5.2.8.3 Key Developments
  129.       5.2.8.4 SWOT Analysis
  130.       5.2.8.5 Key Strategies
  131.     5.2.9 IBM Corporation (US)
  132.       5.2.9.1 Financial Overview
  133.       5.2.9.2 Products Offered
  134.       5.2.9.3 Key Developments
  135.       5.2.9.4 SWOT Analysis
  136.       5.2.9.5 Key Strategies
  137.     5.2.10 Qualcomm Inc (US)
  138.       5.2.10.1 Financial Overview
  139.       5.2.10.2 Products Offered
  140.       5.2.10.3 Key Developments
  141.       5.2.10.4 SWOT Analysis
  142.       5.2.10.5 Key Strategies
  143.   5.3 Appendix
  144.     5.3.1 References
  145.     5.3.2 Related Reports
  146. 6 LIST OF FIGURES
  147.   6.1 MARKET SYNOPSIS
  148.   6.2 US MARKET ANALYSIS BY APPLICATION
  149.   6.3 US MARKET ANALYSIS BY TECHNOLOGY
  150.   6.4 US MARKET ANALYSIS BY END-USE
  151.   6.5 US MARKET ANALYSIS BY COMPONENT
  152.   6.6 KEY BUYING CRITERIA OF LIFE SCIENCES
  153.   6.7 RESEARCH PROCESS OF MRFR
  154.   6.8 DRO ANALYSIS OF LIFE SCIENCES
  155.   6.9 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES
  156.   6.10 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES
  157.   6.11 SUPPLY / VALUE CHAIN: LIFE SCIENCES
  158.   6.12 LIFE SCIENCES, BY APPLICATION, 2024 (% SHARE)
  159.   6.13 LIFE SCIENCES, BY APPLICATION, 2024 TO 2035 (USD Billion)
  160.   6.14 LIFE SCIENCES, BY TECHNOLOGY, 2024 (% SHARE)
  161.   6.15 LIFE SCIENCES, BY TECHNOLOGY, 2024 TO 2035 (USD Billion)
  162.   6.16 LIFE SCIENCES, BY END-USE, 2024 (% SHARE)
  163.   6.17 LIFE SCIENCES, BY END-USE, 2024 TO 2035 (USD Billion)
  164.   6.18 LIFE SCIENCES, BY COMPONENT, 2024 (% SHARE)
  165.   6.19 LIFE SCIENCES, BY COMPONENT, 2024 TO 2035 (USD Billion)
  166.   6.20 BENCHMARKING OF MAJOR COMPETITORS
  167. 7 LIST OF TABLES
  168.   7.1 LIST OF ASSUMPTIONS
  169.     7.1.1
  170.   7.2 US MARKET SIZE ESTIMATES; FORECAST
  171.     7.2.1 BY APPLICATION, 2025-2035 (USD Billion)
  172.     7.2.2 BY TECHNOLOGY, 2025-2035 (USD Billion)
  173.     7.2.3 BY END-USE, 2025-2035 (USD Billion)
  174.     7.2.4 BY COMPONENT, 2025-2035 (USD Billion)
  175.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  176.     7.3.1
  177.   7.4 ACQUISITION/PARTNERSHIP
  178.     7.4.1

US Life Sciences Market Segmentation

Life Sciences By Application (USD Billion, 2025-2035)

  • Chronic Disease Management
  • Health and Fitness Tracking
  • Telehealth Services
  • Medication Management

Life Sciences By Technology (USD Billion, 2025-2035)

  • Wearable Devices
  • Applications
  • Remote Patient Monitoring
  • Telemedicine Platforms

Life Sciences By End-use (USD Billion, 2025-2035)

  • Healthcare Providers
  • Patients
  • Insurance Companies
  • Pharmaceutical Companies

Life Sciences By Component (USD Billion, 2025-2035)

  • Hardware
  • Software
  • Services

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓